RPS26 and myelodysplastic syndrome: These distinctive properties of Rps26 may give rise to some of the phenotypic characteristics observed in DBA patients with RPS26 mutations, specifically, the fact that no RPS26-mutated patient has developed myelodysplastic syndrome or cancer, so far (Lipton et al., 2022).